Ferrous Fumarate And Docusate Sodium Extended-Release Tablets
Item Name Code (INC) 47909
Additional Information for Ferrous Fumarate And Docusate Sodium Extended-Release Tablets
Ferrous Fumarate and Docusate Sodium Extended-Release Tablets are a type of medication that falls under the supply class Drugs and Biologicals in the supply group Medical, Dental, and Veterinary Equipment and Supplies.
Ferrous Fumarate is a form of iron supplement, while Docusate Sodium is a stool softener. These tablets are typically used to treat iron deficiency anemia, a condition characterized by low levels of iron in the body. Iron deficiency anemia can lead to symptoms such as fatigue, weakness, and shortness of breath.
The extended-release formulation of these tablets means that the medication is released slowly over time, allowing for a more gradual absorption in the body. This can help to minimize potential side effects and improve the overall effectiveness of the treatment.
It is important to note that these tablets should only be taken under the guidance and supervision of a healthcare professional. They may have specific dosing instructions and potential interactions with other medications or medical conditions that need to be considered.
If you have any further questions or concerns about Ferrous Fumarate and Docusate Sodium Extended-Release Tablets, it is recommended to consult with a healthcare professional or pharmacist for more information.
Related Item Names for INC 47909 Ferrous Fumarate And Docusate Sodium Extended-Release Tablets
NATO Stock Numbers with Item Name 47909 Ferrous Fumarate And Docusate Sodium Extended-Release Tablets Page 1 of 1
- FERRO-SEQUELS
- RNCC: 5 | RNVC: 1 | DAC: 4
- NDC49483-0031-01
- RNCC: 3 | RNVC: 2 | DAC: 4